Complete patient randomization for the XEN1101 Phase 2b X-TOLE clinical trial
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 14 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Xenon anticipates that patient randomization will be completed in the first half of 2021”
What we found
Evidence strength A What the grades mean
The company completed patient randomization for the X-TOLE clinical trial in late June 2021, meeting its commitment to finish by the first half of 2021.
-
A Xenon Pharmaceuticals Inc. 8-K filed 2021-08-11
“Based on the completion in late June of the randomization of 326 patients” ✓ confirmed on the page
Market reaction: the shares moved +9.1% against the S&P 500 over the three sessions around the disclosure (10 Aug 2021 to 13 Aug 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- XEN1101 Phase 2b X-TOLE patient randomization
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Customer
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Xenon Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-XENE-022084 · Corrections policy